Cargando…
Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable
Autores principales: | Dal-Ré, Rafael, Caplan, Arthur L, Voo, Teck Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236980/ https://www.ncbi.nlm.nih.gov/pubmed/35780073 http://dx.doi.org/10.1016/j.ejim.2022.06.018 |
Ejemplares similares
-
Adaptive, platform trials assessing therapies for hospitalized COVID-19 patients: Informed consent forms omitted a few important elements of information
por: Dal-Ré, Rafael, et al.
Publicado: (2023) -
How WHO Solidarity Plus trial participants in countries on four continents are informed in writing
por: Dal-Ré, Rafael, et al.
Publicado: (2023) -
The approach to informed consent in acute care research
por: Dal-Ré, Rafael, et al.
Publicado: (2022) -
Waivers of informed consent in research with competent participants and the Declaration of Helsinki
por: Dal-Ré, Rafael
Publicado: (2023) -
Ensuring that informed consent is really an informed consent: Role of videography
por: Ghooi, Ravindra B.
Publicado: (2014)